A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status
Clinical trial NCT01283386 · TERMINATED
Trial details
- NCT number
- NCT01283386
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-27
- Primary completion
- 2016-03-16
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.